AMZN
Amazon.com, Inc.
AMZN has the edge over BC overall, supported by stronger valuation and stronger modeled upside.
BC
Brunswick Corporation
BC offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
BC Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Stable |
BC's profitability is currently healthy, and its revenue, cash flow and balance sheet are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over BC in the historical PE scenario, which offers more potential upside but is not a forecast.
BC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $31.76 | -58% |
| Fair | 14x | $45.28 | -41% |
| Forward | 14x | $76.50 | — |
| Expensive | 21x | $69.06 | -9.7% |
| Current | 23x | $76.50 | — |
Historical ranges are pointers, not guarantees.
BC's PE is in its expensive range at 23x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
BC Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
BC has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over BC on earnings, with more consistent year-over-year improvement.
BC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.33 | +63% |
| Q3 2026 | $3.27 | +$6.88 |
| Q2 2026 | -$1.27 | -295% |
| Q1 2026 | -$2.06 | -266% |
| Q4 2025 | -$2.08 | -208% |
| Q3 2025 | -$3.61 | -190% |
| Q2 2025 | $0.65 | -87% |
| Q1 2025 | $1.24 | -77% |
| Q4 2024 | $1.93 | -68% |
BC has returned to profit: it earned $3.27 per share over the past year, after losing money the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over BC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over BC on profitability, with a higher operating margin.
BC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +6.9% |
| Q2 2026 | $1.6B | +7.7% |
| Q1 2026 | $1.4B | +13% |
| Q4 2025 | $1.3B | +15% |
| Q3 2025 | $1.4B | +6.8% |
| Q2 2025 | $1.4B | +0.2% |
| Q1 2025 | $1.2B | -10% |
| Q4 2024 | $1.2B | -15% |
BC's revenue is recovering but still below its 2022 peak: $1.5B last quarter, up 6.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +25 points |
| Q2 2026 | 8.3% | +1.2 points |
| Q1 2026 | 3.6% | -1 points |
| Q4 2025 | 3.1% | +8 points |
| Q3 2025 | -18% | -26 points |
| Q2 2025 | 7.1% | -3.8 points |
| Q1 2025 | 4.6% | -3.5 points |
| Q4 2024 | -4.8% | -13 points |
BC's operating margin was 7.2% last quarter, up 25 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
BC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $136.4M | +28% |
| Q2 2026 | $272.4M | +0.4% |
| Q1 2026 | -$121.3M | -$56.2M |
| Q4 2025 | $83.6M | -70% |
| Q3 2025 | $106.5M | +239% |
| Q2 2025 | $271.3M | +66% |
| Q1 2025 | -$65.1M | +$142.3M |
| Q4 2024 | $276.1M | +22% |
BC has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
BC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -400K shares |
| 1 year | -0.9% | -600K shares |
| 3 years | -7% | -4.9M shares |
| 5 years | -17% | -13.2M shares |
| Available history | -24% | -20.5M shares |
BC has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $28.8M |
| Q2 2026 | $15M |
| Q1 2026 | $16.2M |
| Q4 2025 | $15M |
| Q3 2025 | $21.9M |
| Q2 2025 | $17.5M |
| Q1 2025 | $25.6M |
| Q4 2024 | $10M |
BC spent $75M buying back its own shares over the past year, about the same as the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over BC on leverage, with a lower net debt burden relative to earnings.
BC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.8x | Moderate |
| Q2 2026 | 6.5x | High |
| Q1 2026 | 8.1x | High |
| Q4 2025 | 7.3x | High |
| Q3 2025 | 12.2x | High |
| Q2 2025 | 4.0x | Elevated |
| Q1 2025 | 4.0x | High |
| Q4 2024 | 3.5x | Elevated |
BC's net debt is about 2.8 years of its operating earnings (EBITDA), down from 12 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
BC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.3 | Neutral |
| Stochastic | 65.3 | Neutral |
BC's weekly RSI is 53 (neutral) and its Stochastic is 65 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN has the edge over BC on valuation relative to its sector.
BC PE vs Consumer Cyclical Sector
| Metric | BC | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 30% above |
| PE % | 87 | 47 | 40 pts above |
BC is trading at 23x earnings, a 30% premium to the Consumer Cyclical sector's median of 18x.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over BC on trend strength, trading above more of its moving averages.
BC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $69.2 | 11% above |
| 20 week MA | $74.2 | 3.1% above |
| 50 week MA | $77.4 | 1.2% below |
| 100 week MA | $68.6 | 11% above |
| 200 week MA | $75.3 | 1.6% above |
BC's trend is mixed: it's above four of its five weekly moving averages, and 1.6% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over BC on returns for 2026, with the stronger performance.
BC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $60.8 | $81.5 | +34% |
| 2021 | $81.5 | $96.9 | +19% |
| 2022 | $96.9 | $71.4 | -26% |
| 2023 | $71.4 | $96.8 | +35% |
| 2024 | $96.8 | $64.7 | -33% |
| 2025 | $64.7 | $76.1 | +18% |
| 2026 YTD | $76.1 | $76.5 | +0.5% |
BC has finished higher in four of the last six years. It's up 0.5% so far in 2026.